Recombinant Antibody Technology: Its Advent and Advances

References

• Köhler G, Milstein C. Continous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Miller R, Oseroff AR., Stratte PT., et al. Monoclonal antibody therapeutic trials in seven patients with T-cell hybridoma. Blood 1983; 62: 988–995
   PubMed Web of Science ®Google Scholar
• Roder J, Cole S PC, Kozbor D. The EBV-hybridoma technique. Methods Enzymol 1986; 121: 140–167
   PubMed Web of Science ®Google Scholar
• Burton DR. Immunoglobulin G: Functional sites. Mol Immunol 1985; 22: 161–206
   PubMed Web of Science ®Google Scholar
• Kabat EA. The structural basis of antibody complementarity. Adv Protein Chem 1978; 32: 1–75
   PubMedGoogle Scholar
• Boulianne GL., Hozumi N, Shulman MJ. Production of functional chimeric mouse/human antibody. Nature 1984; 312: 643–646
   PubMed Web of Science ®Google Scholar
• Morrison SL., Johnson MJ., Herzenberg LA., et al. Chimeric human antibody molecules: Mouse antigen domains with human constant region domains. Proc Natl Acad Sci USA 1984; 81: 6851–6855
   PubMed Web of Science ®Google Scholar
• Hawley R, Shulman MJ., Murialdo H, et al. Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci USA 1982; 79: 7425–7429
   PubMed Web of Science ®Google Scholar
• Ochi A, Hawley R, Shulman MJ. Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature 1983; 302: 340–342
   PubMed Web of Science ®Google Scholar
• Ochi A, Hawley R, Hawley T, et al. Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci USA 1983; 80: 6351–6355
   PubMed Web of Science ®Google Scholar
• Rice D, Baltimore D. Regulated expression of an immunoglobulin K gene introduced into a mouse lymphoid cell line. Proc Natl Acad Sci USA 1982; 79: 7862–7865
   PubMed Web of Science ®Google Scholar
• Tisch R, Roifman CM., Hozumi N. Functional differences between immunoglobulin M and D expressed on the surface of an immature B-cell line. Proc Natl Acad Sci USA 1988; 85: 6914–6918
   PubMed Web of Science ®Google Scholar
• Boulianne GL., Isenman DE., Hozumi N, et al. Biological properties of chimeric antibodies. Mol Biol Med 1987; 4: 37–39
   PubMedGoogle Scholar
• Liu AY., Robinson RR., Murray ED., et al. Production of a mousehuman chimeric monoclonal antibody to CD20 with potent Fc-dependent biological activity. J Immunol 1987; 139: 3521–3526
   PubMed Web of Science ®Google Scholar
• Steplevski Z, Sun LK., Shearman CW., et al. Biological activity of human-mouse Ig G1, Ig G2, Ig G3 and Ig G4 chimeric monoclonal antibodies with anti-tumor specificity. Proc Natl Acad Sci USA 1988; 85: 4852–4856
   PubMed Web of Science ®Google Scholar
• Oudin J, Cazenave PA. Similar idiotypic specificities in immunoglobulin fractions with different antibody functions or even without detectable antibody function. Proc Natl Acad Sci USA 1971; 63: 2616–2620
   Google Scholar
• Jones PT., Dear PH., Foote J, et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986; 321: 522–529
   PubMed Web of Science ®Google Scholar
• Verhoeyen M, Milstein C, Winter G. Reshaping human antibodies: Grafting an antilysozyme activity. Science 1988; 239: 1534–1536
   PubMed Web of Science ®Google Scholar
• Riechmann L, Clark M, Waldmann H, et al. Reshaping human antibodies for therapy. Nature 1988; 332: 323–327
   PubMed Web of Science ®Google Scholar
• Verhoeyen M, Reichman L. Engineering of antibodies. Bio-Essays 1988; 8: 74–79
   PubMed Web of Science ®Google Scholar
• Winter G, Milstein C. Man-made antibodies. Nature 1991; 349: 293–299
   PubMed Web of Science ®Google Scholar
• Davis TG., Bedzyk WD., Voss EW., et al. Single chain antibody (SCA) encoding genes: One-step construction and expression in eukaryotic cells. Biotechnology 1991; 9: 165–169
   PubMedGoogle Scholar
• Waldman TA. Monoclonal antibodies in diagnosis and therapy. Science 1991; 252: 1657–1662
   PubMed Web of Science ®Google Scholar
• Xiang J, Roder J, Hozumi N. Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR. Mol Immunol 1990; 27: 809–817
   PubMed Web of Science ®Google Scholar
• Buchner J, Rudolph R. Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology 1991; 9: 157–162
   PubMed Web of Science ®Google Scholar
• Plückthun A, Skerra A. Expression of functional antibody Fv and Fab fragments in Escherichia coli. Methods Enzymol 1989; 178: 497–515
   PubMed Web of Science ®Google Scholar
• Hiatt A, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature 1989; 342: 76–78
   PubMed Web of Science ®Google Scholar
• Pastan I, FitzGerald D. Recombinant toxins for cancer treatment. Science 1991; 254: 1173–1177
   PubMed Web of Science ®Google Scholar
• Huston JS., Levinson D, Mudgett-Hunter M, et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci USA 1988; 85: 5879–5883
   PubMed Web of Science ®Google Scholar
• Skerra A, Pückthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988; 240: 1038–1041
   PubMed Web of Science ®Google Scholar
• Riechmann L, Foote J, Winter G. Expression of an antibody Fv fragment in myeloma cells. J Mol Biol 1988; 203: 825–828
   PubMed Web of Science ®Google Scholar
• Williams WV., Moss DA., Kieber-Emmons T, et al. Development of biologically active peptides based on antibody structure. Proc Natl Acad Sci USA 1989; 86: 5537–5541
   PubMed Web of Science ®Google Scholar
• Taub R, Gould RJ., Garsky VM., et al. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem 1989; 264: 259–265
   PubMed Web of Science ®Google Scholar
• Better M, Chang P, Robinson RR., et al. Escherichia coli secretion of an active chimeric antibody fragment. Science 1988; 240: 1041–1043
   PubMed Web of Science ®Google Scholar
• Tramontano A, Janda KD., Lerner RA. Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen. Proc Natl Acad Sci USA 1986; 83: 6736–6740
   PubMed Web of Science ®Google Scholar
• Tramontano A, Janda KD., Lerner RA. Catalytic antibodies. Science 1986; 234: 1566–1570
   PubMed Web of Science ®Google Scholar
• Pollack SJ., Jacobs JW., Schultz PG. Selective chemical catalysis by an antibody. Science 1986; 234: 1570–1572
   PubMed Web of Science ®Google Scholar
• Neuberger MS., Williams GT., Fox RO. Recombinant antibodies possessing novel effector functions. Nature 1984; 312: 604–608
   PubMed Web of Science ®Google Scholar
• Baker MD., Pennell N, Bosnoyan L, et al. Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line. Proc Natl Acad Sci USA 1988; 85: 6432–6436
   PubMed Web of Science ®Google Scholar
• Capecchi MR. Altering the genome by homologous recombination. Science 1989; 244: 1288–1292
   PubMed Web of Science ®Google Scholar
• Chisaka O, Capecchi MR. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeo box gene hox-1.5. Nature 1991; 350: 473–479
   PubMed Web of Science ®Google Scholar
• Amit AG., Mariuzza RA., Phillips S EV, et al. Three dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 1986; 233: 748–753
   Web of Science ®Google Scholar
• Ward ES., Güssow D, Griffiths AD., et al. Binding activities of a repertoire of single immunoglobulin variable domains sereted from Escherichia coli. Nature 1989; 341: 544–546
   PubMed Web of Science ®Google Scholar
• Roberts S, Cheetham JC., Rees AR. Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering. Nature 1987; 328: 731–734
   PubMed Web of Science ®Google Scholar
• Huse WD., Sastry LS., Iverson SA., et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lamda. Science 1989; 246: 1275–1281
   PubMed Web of Science ®Google Scholar
• Mullinax RL., Gross EA., Amberg JR., et al. Identification of human antibody fragment clones specific for tetanus toxoid in a bacteria phage Δ immunoexpression library. Proc Natl Acad Sci USA 1990; 87: 8095–8099
   PubMed Web of Science ®Google Scholar
• Marks JD., Hoogenboom HR., Bonnert TP., et al. By-passing immunization: Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222: 581–597
   PubMed Web of Science ®Google Scholar
• Mosier DE., Gulizlia RJ., Baird SM., et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256–269
   PubMed Web of Science ®Google Scholar
• McCafferty J, Griffiths AD., Winter G, et al. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552–554
   PubMed Web of Science ®Google Scholar
• Kang AS., Barbas CF., Janda KD., et al. Linkage of recognition and replication functions by assembling combinatorial antibodies Fab libraries along phage surfaces. Proc Natl Acad Sci USA 1991; 88: 4363–4366
   PubMed Web of Science ®Google Scholar
• Clackson T, Hoogenboom HR., Griffiths AD., et al. Making antibody fragments using phage display libraries. Nature 1991; 352: 624–628
   PubMed Web of Science ®Google Scholar
• Chang CN., Landolfi NF., Queen C. Expression of antibody Fab domains on bacteriophage surfaces potential use for antibody selection. J Immunol 1991; 147: 3610–3614
   PubMed Web of Science ®Google Scholar
• Duchosal MA., Eming SA., Fisher P, et al. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 1992; 355: 258–262
   PubMed Web of Science ®Google Scholar
• Thor A, Ohuchi N, Szpak CA., et al. The distribution of oncofetal antigen TAG-72 defined by monoclonal antibody B72.3. Cancer Res 1986; 46: 3118–3124
   PubMed Web of Science ®Google Scholar
• Gallinger S, Papa MZ., Reilly RM., et al. Comparative bio-distribution and antibody-dependent cellular cytotoxity of native and heavy chain chimeric antibody. Mol Biother 1991; 3: 197–203
   PubMedGoogle Scholar
• LoBuglio AE., Wheeler RH., Trang J, et al. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response. Proc Natl Acad Sci USA 1989; 86: 4220–4224
   PubMed Web of Science ®Google Scholar
• Hale G, Clark MR., Marcus R, et al. Remission induction in non-Hodgkin's lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 1988; 2(8625)1394–1398
   PubMed Web of Science ®Google Scholar
• Hird V, Verhoeyen M, Badley RA., et al. Tumor localization with a radioactively labelled reshaped human monoclonal antibody. Br J Cancer 1991; 64: 911–914
   PubMed Web of Science ®Google Scholar
• Brown PS., Parenteau GL., Dirbas FM., et al. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival. Proc Natl Acad Sci USA 1991; 88: 2663–2667
   PubMed Web of Science ®Google Scholar
• Brinkmann U, Pai LH., FitzGerald DJ., et al. B3(Fv)-PE 38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc Natl Acad Sci USA 1991; 88: 8616–8620
   PubMed Web of Science ®Google Scholar
• Sahagan BG., Dorai H, Saltzaber-Muller J, et al. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. J Immunol 1986; 137: 1066–1074
   PubMed Web of Science ®Google Scholar
• Colcher D, Bird R, Roselli M, et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J Natl Cancer Inst 1990; 82: 1191–1197
   PubMed Web of Science ®Google Scholar
• Suresh MR., Cuello AC., Milstein C. Bispecific monoclonal antibodies from hybrid hybridomas. Methods Enzymol 1986; 121: 210–227
   PubMed Web of Science ®Google Scholar
• Staerz U, Bevan MJ. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc Natl Acad Sci USA 1986; 83: 1453–1457
   PubMed Web of Science ®Google Scholar
• Ehrlich P. On immunity with special reference to cell life. Proc R Soc 1899–1900; 66: 424–448
   Google Scholar